These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33602641)
1. A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation. Malde S; Grover S; Raj S; Yuan C; Nair R; Thurairaja R; Khan MS Eur Urol Focus; 2022 Jan; 8(1):141-151. PubMed ID: 33602641 [TBL] [Abstract][Full Text] [Related]
2. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review. Kotecha P; Sahai A; Malde S Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Prospective Outcomes of Patients with Non-Muscle Invasive Bladder Cancer After Holmium Laser Ablation. Darrad M; Jah S; Ahmed Z; Syed H J Endourol; 2019 Nov; 33(11):938-945. PubMed ID: 31432709 [No Abstract] [Full Text] [Related]
4. Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective? Wong KA; Zisengwe G; Athanasiou T; O'Brien T; Thomas K BJU Int; 2013 Sep; 112(5):561-7. PubMed ID: 23819486 [TBL] [Abstract][Full Text] [Related]
5. Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia. Syed HA; Talbot N; Abbas A; MacDonald D; Jones R; Marr TJ; Rukin NJ J Endourol; 2013 Jul; 27(7):886-91. PubMed ID: 23537221 [TBL] [Abstract][Full Text] [Related]
6. Outpatient Holmium laser fulguration: A safe procedure for treatment of recurrence of nonmuscle invasive bladder cancer. Rivero Guerra Á; Fernández Aparicio T; Barceló Bayonas I; Pardo Martínez A; Muñoz Guillermo V; Jiménez Peralta D; Carrillo George C; N Pietricica B; Izquierdo Morejón E; Rosino Sánchez A; Romero Hoyuela A; Hita Villaplana G Actas Urol Esp (Engl Ed); 2018 Jun; 42(5):309-315. PubMed ID: 29422357 [TBL] [Abstract][Full Text] [Related]
7. Endometrial resection and ablation techniques for heavy menstrual bleeding. Lethaby A; Penninx J; Hickey M; Garry R; Marjoribanks J Cochrane Database Syst Rev; 2013 Aug; (8):CD001501. PubMed ID: 23990373 [TBL] [Abstract][Full Text] [Related]
8. Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A Prospective Randomized Noninferiority Clinical Trial. Pedersen GL; Erikson MS; Mogensen K; Rosthøj S; Hermann GG Eur Urol; 2023 Feb; 83(2):125-130. PubMed ID: 36058804 [TBL] [Abstract][Full Text] [Related]
9. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. van den Bosch S; Alfred Witjes J Eur Urol; 2011 Sep; 60(3):493-500. PubMed ID: 21664041 [TBL] [Abstract][Full Text] [Related]
10. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. Richards KA; Smith ND; Steinberg GD J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761 [TBL] [Abstract][Full Text] [Related]
11. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones. Dierselhuis EF; Goulding KA; Stevens M; Jutte PC Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: A retrospective cohort study. Grover S; Raj S; Russell B; Mensah E; Nair R; Thurairaja R; Khan MS; Thomas K; Malde S BJUI Compass; 2022 Mar; 3(2):124-129. PubMed ID: 35474725 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Transurethral Laser Surgery Versus Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis and Systematic Review. Xu J; Wang C; Ouyang J; Sun J; Hu C Urol Int; 2020; 104(9-10):810-823. PubMed ID: 32460292 [TBL] [Abstract][Full Text] [Related]
14. Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery. Chhabra A; Roy Chowdhury A; Prabhakar H; Subramaniam R; Arora MK; Srivastava A; Kalaivani M Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012968. PubMed ID: 33629404 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of transurethral laser surgery with holmium laser, KTP laser, 2-micron laser or thulium laser for the treatment of non-muscle invasive bladder carcinoma: a protocol of network meta-analysis. Yu J; Zheng J BMJ Open; 2021 Dec; 11(12):e055840. PubMed ID: 34907074 [TBL] [Abstract][Full Text] [Related]
18. Outpatient holmium laser treatment for recurrent low-grade superficial bladder cancer under local anesthesia. Cano-Garcia MC; Fernandez-Aparicio T; Hidalgo-AGULLò G; Reina-Alcaina L; Carrillo-George C; Rivero-Guerra Á; Miñana-López B Minerva Urol Nefrol; 2016 Apr; 68(2):204-8. PubMed ID: 25658687 [TBL] [Abstract][Full Text] [Related]
20. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]